Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05811403

Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis

The Influence of Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy Using Two Different Calcium Silicate-based Materials on Postoperative Pain and Success Rate in Mature Permanent Molars With Irreversible Pulpitis: A Randomized Clinical Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effect of two flushing agents (epigallocatechin gallate (EGCG) and sodium hypochlorite (NaOCl)) during full pulpotomy using two different calcium silicate-based materials (MTA and premixed bioceramic putty) on postoperative pain, success rate and dentin bridge thickness in mature permanent mandibular molars with irreversible pulpitis. Participants will be divided into four groups based on the flushing fluid and the pulp capping material to be used.

Conditions

Interventions

TypeNameDescription
OTHEREpigallocatechin gallate (EGCG)Epigallocatechin gallate (EGCG) is a white powder that can be obtained from tea leaves. It accounts for 50-60 % of catechin content of tea polyphenols with a wide range of biological activities including antioxidant, antimicrobial, anti-inflammatory, immune regulatory, anti-tumour effects.
OTHERSodium hypochlorite (NaOCl)Sodium hypochlorite (NaOCl) is an excellent non-specific proteolytic and antimicrobial agent that provides disinfection of the dentin-pulp interface.
OTHERMineral trioxide aggregate (MTA)Mineral trioxide aggregate (MTA) is the material of choice for pulp capping in vital pulp therapy.
OTHERPremixed bioceramic puttyBioceramic putty is a premixed, ready-to-use calcium silicate-based material which can be used as a pulp capping material.

Timeline

Start date
2023-07-01
Primary completion
2025-06-30
Completion
2026-06-30
First posted
2023-04-13
Last updated
2026-03-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05811403. Inclusion in this directory is not an endorsement.